Facilitated By

San Antonio Medical Foundation

A SINGLE CENTER, OPEN LABEL, MARKETING TRIAL TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF AN OTC SALICYLIC ACID REGIMEN FOR THE TREATMENT OF COMMON WARTS (VERRUCA VULGARIS) IN CHILDREN AND ADOLESCENTS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Browning,John C
Funded by
VIROXIS
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Infectious Disease